An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd has announced the application for the quotation of 12,941,176 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective February 28, 2025. This move is part of a previously announced transaction and is expected to bolster the company’s financial position, potentially enhancing its market presence and offering new opportunities for stakeholders.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on developing advanced imaging solutions. The company’s primary product is a cutting-edge lung imaging technology that aims to enhance the diagnosis and treatment of respiratory conditions.
YTD Price Performance: -12.50%
Average Trading Volume: 939,388
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$173.9M
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.